Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FISV | RBRK |
|---|---|---|
| Price | $45.45 | $115.72 |
| Change today | ▲ 0.60% | ▲ 1.09% |
| Market cap | $24.17B | $23.99B |
| Return, 3 months | -10.4% | +41.1% |
| Return, year to date | -32.3% | +51.3% |
| Return, 1 year | -64.0% | +40.4% |
| P/E (TTM) | 8.7 | -91.1 |
| P/B | 0.9 | -48.0 |
| P/E percentile vs own 5y | 2nd | 0th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -4.1% | +37.9% |
| Net profit growth (YoY) | -38.8% | +35.6% |
| Gross margin | 56.2% | 80.2% |
| Operating margin | 21.4% | -18.3% |
| Net margin | 13.4% | -16.5% |
| Return on equity | 10.7% | – |
| Analyst target vs. price | +35.8% | +3.3% |
| Analyst buy share | 16% | 100% |
| RSI (14) | 31 | 64 |
| 30-day volatility | 31.6% | 81.0% |
| Max drawdown, 1 year | -66.0% | -52.0% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
